rdf:type |
|
lifeskim:mentions |
umls-concept:C0007589,
umls-concept:C0007634,
umls-concept:C0026473,
umls-concept:C0029016,
umls-concept:C0079784,
umls-concept:C0080055,
umls-concept:C0439851,
umls-concept:C1160185,
umls-concept:C1280500,
umls-concept:C1511938,
umls-concept:C1552114,
umls-concept:C1552596,
umls-concept:C1704259,
umls-concept:C1705987,
umls-concept:C1947931
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-8-28
|
pubmed:abstractText |
Expression of exogenous wt-p53 in different tumor cell lines can induce growth arrest, apoptosis, or differentiation. Several experimental works have highlighted the relevance of cellular context in the determination of p53-mediated final outcomes. We recently observed that these diverse wt-p53 effects can also be induced by overexpressing wt-p53 in a single cell type-the 32D myeloid progenitors-transformed with different activated oncogenes. Here we show that 32D cells transformed with two different oncogenes, v-src or c-fms [S301,F969], both belonging to the CSF-1 transduction pathway, respond to exogenous wt-p53 expression with the same final outcome-monocytic differentiation. This result is particularly significant since 32D cells do not spontaneously express the CSF-1 receptor, whereas they undergo granulocytic differentiation upon G-CSF stimulation. These data strongly support the idea that wt-p53 suppressing effects result from interactions between p53 activity and the signaling pathways activated in different transformed cells.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0950-9232
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
607-11
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9247315-Cell Differentiation,
pubmed-meshheading:9247315-Cell Division,
pubmed-meshheading:9247315-Cell Line, Transformed,
pubmed-meshheading:9247315-Cell Survival,
pubmed-meshheading:9247315-Gene Expression Regulation,
pubmed-meshheading:9247315-Genes, Tumor Suppressor,
pubmed-meshheading:9247315-Genes, fms,
pubmed-meshheading:9247315-Genes, src,
pubmed-meshheading:9247315-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:9247315-Interleukin-3,
pubmed-meshheading:9247315-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:9247315-Monocytes,
pubmed-meshheading:9247315-Recombinant Proteins,
pubmed-meshheading:9247315-Signal Transduction,
pubmed-meshheading:9247315-Stem Cells,
pubmed-meshheading:9247315-Tumor Suppressor Protein p53
|
pubmed:year |
1997
|
pubmed:articleTitle |
Oncogenes belonging to the CSF-1 transduction pathway direct p53 tumor suppressor effects to monocytic differentiation in 32D cells.
|
pubmed:affiliation |
Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, C.R.S., Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|